Zafgen is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for patients affected by a range of metabolic diseases
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.